Dr. Bickman also points out that some versions of these drugs might stimulate the production of new fat cells. Consequently, after discontinuing Ozempic, individuals might regain fat more rapidly.
Originally developed for type 2 diabetes, Ozempic is now widely used for weight loss. However, Dr. Ben Bickman of Brigham Young University warns it may cause significant muscle and bone loss—up to 40% of total weight lost—raising long-term health concerns.
He also notes that the drug may spur new fat cell growth, increasing fat regain after stopping. Clinical trials show users can lose over 10% of their muscle mass in extended use. Bickman adds that Ozempic’s appetite-suppressing effect may fade after two years, making weight maintenance harder.
Post Comment